Viewing Study NCT03608657


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-02-28 @ 8:19 AM
Study NCT ID: NCT03608657
Status: COMPLETED
Last Update Posted: 2024-06-05
First Post: 2018-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE)
Sponsor: Amgen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Arthritis, Psoriatic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Psoriatic Arthritis View
None Canada View
None CC-10004 View
None Apremilast View
None APPRAISE View
None Safety View
None Non-interventional View
None Observation View
None DMARDs View